4268 Federal Register / Vol. 63, No. 18 /Wednesday, January 28, 1998 / Notices

received at the Reserve Bank indicated

or the offices of the Board of Governors

not later than February 23, 1998.

A. Federal Reserve Bank of

Philadelphia (Michael E. Collins, Senior

Vice President) 100 North 6th Street,

Philadelphia, Pennsylvania 19105-1521:

1. Commerce Bancorp, Inc., Cherry

Hill, New Jersey; to acquire A.H.

Williams & Co., Inc., Philadelphia,

Pennsylvania, and thereby engage in the

following: underwriting and dealing in

municipal revenue bonds, private

ownership industrial development

bonds issued for traditional government

services, mortgage-backed securities,

commercial paper, and consumer

receivable-related securities. See

Citicorp, 73 Fed. Res. Bull. 473 (1987);

Chemical New York Corporation, 73

Fed. Res. Bull. 731 (1987); Crestar

Financial Corporation, 83 Fed. Res.

Bull. 512 (1997); activities that are usual

in connection with making, acquiring,

brokering, or servicing loans or other

extensions of credit, pursuant to §

225.28(b)(2) of the Board’s Regulation Y;

leasing personal or real property or

acting as agent, broker, or adviser in

leasing such property, pursuant to §

225.28(b)(3) of the Board’s Regulation Y;

acting as investment or financial

advisor, pursuant to § 225.28(b)(6) of

the Board’s Regulation Y; providing

agency transactional services for

customer investments, pursuant to §

225.28(b)(7) of the Board’s Regulation Y;

underwriting and dealing in bankeligible securities, pursuant to §

225.28(b)(8)(i) of the Board’s Regulation

Y; engaging as principal in investment

and trading activities, pursuant to §

225.28(b)(8)(ii) of the Board’s Regulation

Y; and providing management

consulting and employee benefits

counseling services, pursuant to §

225.28(b)(9) of the Board’s Regulation Y.

B. Federal Reserve Bank of

Richmond (A. Linwood Gill III,

Assistant Vice President) 701 East Byrd

Street, Richmond, Virginia 23261-4528:

1. One Valley Bancorp, Inc.,

Charleston, West Virginia; to acquire

FFVA Financial Corporation,

Lynchburg, Virginia, and thereby

indirectly acquire its subsidiary, First

Federal Savings Bank of Lynchburg,

Lynchburg, Virginia, and thereby engage

in operating a savings and loan

association, pursuant to §

225.28(b)(4)(ii) of the Board’s Regulation

Y.

Board of Governors of the Federal Reserve

System, January 23, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–2064 Filed 1–27–98; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

National Committee on Vital and Health

Statistics: Meetings

Pursuant to the Federal Advisory

Committee Act, the Department of

Health and Human Services announces

the following advisory committee

meeting.

Name: National Committee on Vital and

Health Statistics (NCVHS), Subcommittee on

Health Data Needs, Standards, and Security.

Times and Dates: 9:00 a.m.–5:00 p.m.,

February 9, 1998. 9:00 a.m.–5:00 p.m.,

February 10, 1998.

Place: Room 303A, Hubert H. Humphrey

Building, 200 Independence Avenue, SW,

Washington, D.C. 20201.

Status: Open.

Purpose: Under the Administrative

Simplification provisions of Public Law 104–

191, the Health Insurance Portability and

Accountability Act of 1996 (HIPAA), the

Secretary of Health and Human Services is

required to adopt standards for specified

transactions to enable health information to

be exchanged electronically. The law

requires that, within 24 months of adoption,

all health plans, health care clearinghouses,

and health care providers who choose to

conduct these transactions electronically

must comply with these standards. The law

also requires the Secretary to adopt a number

of supporting standards including standards

for code sets and classifications systems. The

Secretary is required to consult with the

National Committee on Vital and Health

Statistics (NCVHS) in complying with these

provisions. The NCVHS is the Department’s

federal advisory committee on health data,

privacy and health information policy.

The NCVHS already has provided

recommendations to HHS relating to most of

the transaction and supporting standards,

and proposed regulations adopting those

standards are being prepared by HHS for

public review and comment in the Federal

Register. HIPAA allowed an additional

twelve months for adoption of the standard

for claims attachments. To assist in the

development of the NCVHS

recommendations to HHS relating to the

claims attachment standards, the NCVHS

Subcommittee on Health Data Needs,

Standards, and Security has scheduled a

public meeting on February 9–10, 1998. At

the meeting, the Subcommittee will obtain

the perspectives, concerns and

recommendations of interested and affected

parties relating to this standard. In addition,

the Subcommittee will review and discuss its

overall work plan for the year, including

medical classification issues and activities

relating to population based-data.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey building by non-government

employees. Thus, persons without a

government identification card may need to

have the guard call for an escort to the

meeting.

Contact Person for More Information:

Substantive program information as well as

summaries of the meeting and a roster of

committee members may be obtained from

Bill Braithwaite, lead Subcommittee staff,

Office of the Assistant Secretary for Planning

and Evaluation, DHHS, Room 440–D,

Humphrey Building, 200 Independence

Avenue S.W., Washington, D.C. 20201,

telephone (202) 260–0546, or Marjorie S.

Greenberg, Executive Secretary, NCVHS,

NCHS, CDC, Room 1100, Presidential

Building, 6525 Belcrest Road, Hyattsville,

Maryland 20782, telephone (301) 436–7050.

Information also is available on the NCVHS

home page of the HHS website: http://

aspe.os.dhhs.gov/ncvhs/, where the agenda

for the meeting will be posted when

available.

Dated: January 21, 1998.

James Scanlon,

Director, Division of Data Policy, Office of

the Assistant Secretary for Planning and

Evaluation.

[FR Doc. 98–2041 Filed 1–27–98; 8:45 am]

BILLING CODE 4151–04–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Health Resources and Service

Administration; Statement of

Delegation of Authority

Notice is hereby given that I have

delegated to the Administrator of the

Health Resources and Services

Administration (HRSA), with authority

to redelegate, all authorities vested in

the Secretary of Health and Human

Services under Title XXVI of the Public

Health Service Act, Public Law 101–

381, The Ryan White Comprehensive

AIDS Resources Emergency Act of 1990,

as amended by Public Law 104–146, as

amended hereafter, pertaining to the

HIV Health Care Services Program, as

follows:

1. Part A (Title I of the CARE Act and

Section 2601–07 of the PHS Act)—

Emergency Relief for Areas with

Substantial Need for Services;

2. Part B (Title II of the CARE Act and

Sections 2611–21 of the PHS Act)—Care

Grant Program to States and Territories;

3. Part C (Title III of the CARE Act

and Sections 2651–54 of the PHS Act)—

Early Intervention Services at

community health clinics;

4. Part D (Title IV of the CARE Act

and Section 2671 of the PHS Act)—

Grants for Coordinated Services and

Access to Research for Women, Infants,

Children and Youth;

5. Part F.I., Section 2691 of the PHS

Act—Special Projects of National

Significance (SPNS);
Federal Register / Vol. 63, No. 18 /Wednesday, January 28, 1998 / Notices 4269

6. Part F.II(a)., Section 2692(a) of the

PHS Act—AIDS Education and Training

Centers (AETC);

7. Part F.II.(b)., Section 2692(b) of the

PHS Act—Dental Schools

Reimbursement Program.

This delegation supersedes the

delegation memorandum from the

Assistant Secretary for Health to the

HRSA Administrator, dated May 24,

1991.

This delegation is effective upon date

of signature. In addition, I hereby affirm

and ratify any actions taken by the

HRSA Administrator or any

subordinates which, in effect, involved

the exercise of the authorities delegated

herein prior to the effective date of the

delegation.

Dated: January 20, 1998.

Donna E. Shalala,

Secretary.

[FR Doc. 98–2040 Filed 1–27–98; 8:45 am]

BILLING CODE 4160–15–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee on

Immunization Practices (ACIP).

Times and Dates: 8:30 a.m.–5:15 p.m.,

February 11, 1998; 8:30 a.m.–1:15 p.m.,

February 12, 1998.

Place: CDC, Auditorium B, Building 2,

1600 Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents. In

addition, under 42 U.S.C. 1396s, the

Committee is mandated to establish and

periodically review and, as appropriate,

revise the list of vaccines for administration

to vaccine-eligible children through the

Vaccines for Children (VFC) program, along

with schedules regarding the appropriate

periodicity, dosage, and contraindications

applicable to the vaccines.

Matters To Be Discussed: Agenda items

will include updates from the National

Center for Infectious Diseases; the National

Immunization Program; the Vaccine Injury

Compensation Program; the National Vaccine

Program; update on influenza A(H5N1):

epidemiologic and virologic surveillance and

present status of vaccine development;

update on influenza surveillance—U.S. and

worldwide; influenza vaccination and

Guillain Barre syndrome: update and

proposed changes to ACIP recommendations;

proposed changes to the 1998–1999 ACIP

recommendations for prevention and control

of influenza; immunization of bone marrow

transplant recipients recommendations on

the use of Rotashield (rotavirus vaccine) as

part of the routine childhood immunization

schedule; report of work group on

computerization of ACIP recommendations;

ACIP combination vaccines recommendation;

comprehensive resolutions for the Vaccines

for Children (VFC) Program; vaccine

identification standards initiative; and

alopecia associated with hepatitis B

vaccination. Other matters of relevance

among the committee’s objectives may be

discussed.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Gloria A. Kovach, Committee Management

Specialist, CDC, 1600 Clifton Road, NE, M/

S D–50, Atlanta, Georgia 30333, telephone

404/639–7250.

Dated: January 21, 1998.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 98–1998 Filed 1–27–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committees; Notice of

Meetings

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing a

tentative schedule of forthcoming

meetings of its public advisory

committees for 1998. At the request of

the Commissioner of Food and Drugs

(the Commissioner), the Institute of

Medicine (the IOM) conducted a study

of the use of FDA’s advisory

committees. The IOM recommended

that the agency publish an annual

tentative schedule of its meetings in the

Federal Register. In response to that

recommendation, FDA is publishing its

annual tentative schedule of meetings

for 1998.

FOR FURTHER INFORMATION CONTACT:

Donna M. Combs, Committee

Management Office (HFA–306), Food

and Drug Administration, 5600 Fishers

Lane, Rockville, MD 20857, 301–827–

4820.

SUPPLEMENTARY INFORMATION: The IOM,

at the request of the Commissioner,

undertook a study of the use of FDA’s

advisory committees. In its final report,

the IOM recommended that FDA adopt

a policy of publishing an advance yearly

schedule of its upcoming public

advisory committee meetings in the

Federal Register. FDA has implemented

this recommendation. A tentative

schedule of forthcoming meetings will

be published annually in the Federal

Register. The annual publication of

tentatively scheduled advisory

committee meetings will provide both

advisory committee members and the

public with the opportunity, in advance,

to schedule attendance at FDA’s

upcoming advisory committee meetings.

The schedule is tentative and

amendments to this notice will not be

published in the Federal Register. FDA

will publish a Federal Register notice at

least 15 days in advance of each

upcoming advisory committee meeting,

announcing the meeting (21 CFR 14.20).

The following list announces FDA’s

tentatively scheduled advisory

committee meetings for 1998:

Committee Name Dates of Meetings InformationLine Code

OFFICE OF THE COMMISSIONER

Science Board to the Food and Drug Administration May 19 ......................................................................... 12603

September 15

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Allergenic Products Advisory Committee March 23–24 ................................................................ 12388

September 14–15

Biological Response Modifiers Advisory Committee March 23–24 ................................................................ 12389